David Garrett Gossman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-3187 Fax: 715-735-5848 |
News Archive
Have you ever wondered whether the brains of right-handed people work differently from those of left-handers? Is it possible to distinguish between them by observing their brain activity in response to stimuli or tasks?
This year marks both the 10th anniversary of the Affordable Care Act (ACA), and a pivotal moment for its future because of the national election and a pending Supreme Court case.
Despite significant investment in research and development by pharmaceutical companies, the last decade has seen a marked decline in the number of drugs developed and approved for schizophrenia. A multi-day symposium at the New York Academy of Sciences on Wednesday, March 9 - Friday, March 11 will convene world-leading experts in clinical, translational, and basic neuroscience to address this problem by examining novel, state-of-the-art approaches to schizophrenia drug development.
Scientists at the Roskamp Institute, a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder.
Baxter International Inc. announced today the results of a phase III study evaluating the safety and efficacy of ARTISS in 75 patients.
› Verified 8 days ago